FZD2 and cancer: Moreover, Figure 2C further demonstrates significant upregulation of FZD2 in tumor tissues across a range of cancers, including BLCA, BRCA, CHOL, COAD, ESCA, HNSC, LIHC, STAD, and UCEC, with lower expression observed in KICH, KIRC, PRAD, and THCA.